Epitalon (also spelled Epithalon or Epithalone) is a synthetic tetrapeptide (four amino acids) based on epithalamin — a naturally occurring peptide extract from the pineal gland. It was developed by Russian gerontologist Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology.
Epitalon's primary mechanism is activation of telomerase — the enzyme responsible for maintaining telomere length. Telomeres are the protective caps on the ends of chromosomes that shorten with each cell division. When telomeres become critically short, cells enter senescence (they stop dividing) or undergo apoptosis (programmed cell death). This progressive telomere shortening is one of the fundamental mechanisms of biological aging.
By activating telomerase, Epitalon promotes the elongation of telomeres, effectively extending the replicative lifespan of cells. It also stimulates melatonin production from the pineal gland, which declines significantly with age, contributing to sleep disruption and loss of circadian rhythm regulation.
Additional mechanisms include antioxidant effects (protecting DNA from oxidative damage) and modulation of gene expression patterns associated with aging.
Epitalon has been studied primarily in Russian research institutions, with over 100 publications spanning three decades.
Telomerase Activation: In human cell culture studies, Epitalon activated telomerase in somatic cells, leading to telomere elongation. Human fetal fibroblast cultures treated with Epitalon showed a 2.4-fold increase in the number of cell divisions before senescence compared to controls.
Lifespan Extension: In multiple animal models (rats, mice, Drosophila), Epitalon administration significantly extended lifespan. In one study, old rats receiving Epitalon showed a 13.3% increase in mean lifespan. Similar studies showed improved physiological function in aged animals.
Melatonin Production: Clinical studies in elderly patients demonstrated that Epitalon restored melatonin production toward youthful levels, improving sleep quality and circadian rhythm regulation. This is significant because pineal gland calcification and declining melatonin are hallmarks of aging.
Cancer: Several studies explored Epitalon's effect on spontaneous tumor development in aged animals. Results showed reduced tumor incidence in Epitalon-treated groups compared to controls, potentially related to improved telomere maintenance and immune surveillance.
Retinal Health: Research on retinal pigment epithelium cells showed that Epitalon promoted preservation of retinal structure and function in aged animals, suggesting potential applications in age-related retinal degeneration.
The following protocols are reported from clinical practice. This is not medical advice. Consult a licensed healthcare provider before starting any peptide therapy.
Epitalon is administered via subcutaneous or intravenous injection. Reported clinical approaches include:
Standard Longevity Protocol: 5–10 mg subcutaneously per day for 10–20 consecutive days, repeated every 4–6 months. This pulsed approach mirrors the dosing used in the original Russian clinical research.
Maintenance Protocol: 5 mg subcutaneously, 2–3 times per week as ongoing maintenance between intensive courses.
Khavinson Protocol (Original): 10 mg per day for 10 days, administered once or twice per year. This is the protocol most closely aligned with the published research.
Common Stacks: Epitalon is frequently combined with GHK-Cu, NAD+, and BPC-157 in comprehensive longevity protocols. The combination of telomerase activation (Epitalon), gene expression reset (GHK-Cu), cellular energy restoration (NAD+), and tissue repair (BPC-157) targets multiple pillars of aging.
Cycle Length: 10–20 day intensive courses, repeated every 4–6 months.
Epitalon has an excellent safety profile supported by decades of research and clinical use in Russia. Commonly reported effects are minimal and include mild injection site reactions and occasional headache.
The theoretical concern with telomerase activation is cancer risk, since cancer cells use telomerase to achieve immortality. However, the research on Epitalon has not shown increased cancer incidence — in fact, some studies showed reduced tumor development. This may be because Epitalon's telomerase activation operates within normal regulatory frameworks rather than the uncontrolled telomerase expression seen in cancer cells.
Verified suppliers with third-party testing and COA documentation. Use code POWER where applicable.
Epitalon activates telomerase and extends telomeres, which addresses one of the fundamental biological mechanisms of aging. It also restores melatonin production and improves gene expression patterns. While "reversing aging" is an oversimplification, the evidence supports that Epitalon can slow key aspects of cellular aging and improve age-related functional decline.
The most common protocol follows the original Russian research: a 10–20 day intensive course (5–10 mg/day), repeated every 4–6 months. Some providers add low-dose maintenance between courses. The pulsed approach is designed to stimulate telomerase activity without continuous exposure.
This is a legitimate theoretical concern, but the published research on Epitalon has not shown increased cancer incidence. Some studies actually showed reduced tumor development in treated animals. The current understanding is that Epitalon activates telomerase within normal regulatory pathways, unlike the uncontrolled telomerase expression in cancer cells.
Epitalon stimulates your pineal gland to produce more of its own melatonin, which is different from exogenous melatonin supplementation. Some providers recommend transitioning from melatonin supplements to Epitalon to support natural melatonin production. Discuss timing with your provider to avoid excessive melatonin overlap.
Take our 2-minute quiz to get a personalized peptide recommendation based on your goals, experience level, and health priorities.
Take the Peptide Quiz →This content is for informational and educational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, cure, or prevent any disease or condition. Always consult with a qualified healthcare provider before starting any peptide therapy or supplement regimen. Peptide protocols described on this page reflect reported clinical practices and published research — not recommendations. Individual results may vary. Read full disclaimer.
Affiliate Disclosure: PeptideOnline.co participates in affiliate programs with suppliers featured on this page. We may earn a commission on qualifying purchases at no additional cost to you. Our editorial content is independent and not influenced by affiliate relationships. Learn more.